FOSUN INTL(HK:00656) Xin Lang Cai Jing·2026-01-18 10:36Core Viewpoint - The forum emphasizes the resilience, innovation, and aspirations of Zhejiang merchants amidst the waves of the Chinese economy, highlighting the importance of maintaining a competitive edge through innovation and market economy principles [3][13]. Economic Outlook - The current economic climate is warmer compared to the previous year, with negative factors gradually being digested, indicating the resilience of the Chinese economy [3][4]. - There is optimism for 2026, with expectations for significant growth and opportunities for businesses to excel [3][4]. Innovation and Competitiveness - The strength of China's economy is attributed to its market economy and the resilience of private enterprises, particularly in emerging sectors like AI, robotics, and biomedicine [4][14]. - Fosun's biopharmaceutical platform, Fuhong Hanlin, is set to achieve breakthroughs with multiple products expected to be globally competitive by 2025, including the world's first successful PD-1 monoclonal antibody for gastric cancer [4][14]. Globalization Strategy - Fosun is committed to globalization, with operations in over 40 countries and regions, and overseas revenue reaching 46.67 billion yuan, accounting for 53% of total revenue in the first half of 2025 [18]. - The company aims to leverage China's capabilities and resources to enhance its global presence and competitiveness [18]. Consumer Market Insights - The Chinese consumer market, with over a billion people, presents continuous opportunities, emphasizing the need for companies to enhance product quality and innovation [16][17]. - Fosun's ventures in tourism and consumer goods have seen positive market responses, with high occupancy rates in hotels and successful product launches [16][17].